500

0

Patient-reported outcomes: asking people with lung cancer how they are

Web Team 05/07/2026 Web Team 05/07/2026

Patient-reported outcomes: asking people with lung cancer how they are

Read More

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

Web Team 04/07/2026 Web Team 04/07/2026

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

Read More

President’s Mid Year Report: January to June 2026

Web Team 01/07/2026 Web Team 01/07/2026

President’s Mid Year Report: January to June 2026

Read More

Access to Treatment Atlas: compare lung cancer treatment access across Europe

Web Team 01/07/2026 Web Team 01/07/2026

Access to Treatment Atlas: compare lung cancer treatment access across Europe

Read More

Web Team 01/07/2026 Web Team 01/07/2026

Lung Cancer Europe updates its identity

Read More

What the EU Critical Medicines Act means for lung cancer

Web Team 01/07/2026 Web Team 01/07/2026

What the EU Critical Medicines Act means for lung cancer

Read More

England catches up on cemiplimab for advanced lung cancer

Web Team 01/07/2026 Web Team 01/07/2026

England catches up on cemiplimab for advanced lung cancer

Read More

HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC

Web Team 01/07/2026 Web Team 01/07/2026

HARMONi-7: European sites now open for Phase 3 ivonescimab trial in high PD-L1 NSCLC

Read More

EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer

Web Team 30/06/2026 Web Team 30/06/2026

EU Progress on 2030 Clinical Trial Targets: What It Means for Lung Cancer

Read More

Could innovative medicines save more than they cost? What this new report means for lung cancer

Web Team 25/06/2026 Web Team 25/06/2026

Could innovative medicines save more than they cost? What this new report means for lung cancer

Read More

Lung cancer in women: what a new study shows about treatment side effects

Web Team 24/06/2026 Web Team 24/06/2026

Lung cancer in women: what a new study shows about treatment side effects

Read More

Early-onset lung cancer: why are more younger adults being diagnosed?

Web Team 22/06/2026 Web Team 22/06/2026

Early-onset lung cancer: why are more younger adults being diagnosed?

Read More

Biomarker testing is moving faster than ever. Is Europe keeping up?

Web Team 20/06/2026 Web Team 20/06/2026

Biomarker testing is moving faster than ever. Is Europe keeping up?

Read More

Lung cancer and heart health: understanding the two-way connection

Web Team 20/06/2026 Web Team 20/06/2026

Lung cancer and heart health: understanding the two-way connection

Read More

Hotter Summers, Dirtier Air: Heatwaves and Lung Cancer in Europe

Web Team 19/06/2026 Web Team 19/06/2026

Hotter Summers, Dirtier Air: Heatwaves and Lung Cancer in Europe

Read More

Could ageing lung cells increase lung cancer risk?

Web Team 16/06/2026 Web Team 16/06/2026

Could ageing lung cells increase lung cancer risk?

Read More

Small cell lung cancer and mental health: experiences reported by Europeans impacted by the disease

Web Team 14/06/2026 Web Team 14/06/2026

Small cell lung cancer and mental health: experiences reported by Europeans impacted by the disease

Read More

Lung cancer in people who have never smoked: what the evidence now shows

Web Team 13/06/2026 Web Team 13/06/2026

Lung cancer in people who have never smoked: what the evidence now shows

Read More

GLP-1 drugs and lung cancer: what the ASCO 2026 evidence shows, and what it does not

Web Team 12/06/2026 Web Team 12/06/2026

GLP-1 drugs and lung cancer: what the ASCO 2026 evidence shows, and what it does not

Read More

What Could a New Iron Discovery Mean for Lung Cancer Immunotherapy?

Web Team 11/06/2026 Web Team 11/06/2026

What Could a New Iron Discovery Mean for Lung Cancer Immunotherapy?

New research published in Nature Cancer has identified iron accumulation as a trigger for the destruction of CAR-T immune cells. We explore what this unexpected finding could mean for the future of lung cancer treatment.

Read More